MoneyWorks4Me

Marksans Pharma’s arm gets marketing authorization for two products

17 Nov 2025 Evaluate

Marksans Pharma’s wholly owned subsidiary -- Relonchem in UK has received marketing authorization for its Mefenamic Acid 250 mg Film-Coated Tablets and Mefenamic Acid 500 mg Film-Coated Tablets from UK Medicines & Healthcare products Regulatory Agency (UK MHRA). 

Marksans Pharma is engaged in Research, Manufacturing & Marketing of generic pharmaceutical formulation in the global markets.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..